home / stock / cfrx / cfrx news

CFRX News and Press, ContraFect Corporation From 04/27/23

Stock Information
Company Name: ContraFect Corporation
Stock Symbol: CFRX
Market: NASDAQ
Website: contrafect.com
Menu
CFRX CFRX Quote CFRX Short CFRX News CFRX Articles CFRX Message Board
Get CFRX Alerts

News, Short Squeeze, Breakout and More Instantly...
CFRX - MBLY, NUWE and OMQS among mid-day gainers

2023-04-27 12:24:19 ET Gainers: TOP Financial Group Limited ( TOP ) +186% . Evelo Biosciences ( EVLO ) +184% . ContraFect Corporation ( CFRX ) +68% . U Power Limited Ordinary Shares ( UCAR ) +40% . Atomera Incorporated ( ATOM ) +33...
CFRX - MBLY, NUWE and OMQS among mid-day movers

2023-04-27 12:24:19 ET Gainers: TOP Financial Group Limited ( TOP ) +186% . Evelo Biosciences ( EVLO ) +184% . ContraFect Corporation ( CFRX ) +68% . U Power Limited Ordinary Shares ( UCAR ) +40% . Atomera Incorporated ( ATOM ) +33...

CFRX - ContraFect, Accuray top healthcare gainers; Baudax, 4D Molecular among losers

2023-04-27 10:01:57 ET Gainers: ContraFect ( CFRX ) +112% . Accuray ( ARAY ) +14% . Mainz Biomed ( MYNZ ) +15% . Mangoceuticals ( MGRX ) +14% . Immix Biopharma ( IMMX ) +9% . Losers: Baudax Bio ( BXRX ) -52% ....

CFRX - GRWG, LGMK and CFRX are among pre market gainers

2023-04-27 08:33:01 ET ContraFect Corporation ( CFRX ) +65% . Atomera ( ATOM ) +36% Q1 earnings call release U Power Limited Ordinary  ( UCAR ) +34% . Mobilicom Limited ( MOB ) +19% Secures A $430,000 Repeat Order for Mobile Ground Contro...
CFRX - ContraFect Announces First Patient Dosed in the Phase 1b/2 Study of Exebacase in Patients with Chronic Prosthetic Joint Infections of the Knee

YONKERS, N.Y., April 26, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of...

CFRX - Augmedix, CNS top healthcare gainers; Windtree, Nevro among losers

2023-04-20 10:04:03 ET Gainers: Augmedix ( AUGX ) +67% . CNS Pharmaceuticals ( CNSP ) +65% . Petros Pharmaceuticals ( PTPI ) +36% . ContraFect ( CFRX ) +20% . Dermata Therapeutics ( DRMA ) +14% . Losers: Windtree Therapeut...

CFRX - ContraFect Data Presentations at the 33rd Annual ECCMID Meeting Highlight the Potential Efficacy of Lysin CF-370 Against Antibiotic Resistant Gram-negative Pathogens

YONKERS, N.Y., April 20, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of...
CFRX - XPEV, HIVE and BTBT among pre-market losers

2023-04-19 08:21:42 ET Allarity Therapeutics ( ALLR ) -33% . Femasys ( FEMY ) -25% anounces $3.9 million registered direct offering. Oblong ( OBLG ) -21% . Gamida Cell ( GMDA ) -16% on public offering . United Insurance Holdings ( ...

CFRX - BXRX, GMBL and CYTO among mid-day movers

2023-04-18 12:50:32 ET Gainers: BELLUS Health ( BLU ) +98% . Dermata Therapeutics ( DRMA ) +68% . Gamida Cell ( GMDA ) +53% . Allarity Therapeutics ( ALLR ) +45% . Esports Entertainment Group ( GMBL ) +35% . Altamira Therapeu...

CFRX - Dermata, Bellus top healthcare gainers; China Jo-Jo Drugstores, ContraFect among losers

2023-04-18 10:04:36 ET Gainers: Dermata Therapeutics ( DRMA ) +108% . BELLUS Health ( BLU ) +99% . Allarity Therapeutics ( ALLR ) +69% . Gamida Cell ( GMDA ) +37% . YS Biopharma ( YS ) +28% . Losers: China Jo-Jo Drugs...
Previous 10 Next 10